Sofinnova Investments
$2.0B 13F equity value
76 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | 1,550,280 | $310M | 15.5% |
| BMY | Bristol-Myers Squibb Co | 1,988,721 | $121M | 6.0% |
| JAZZ | Jazz Pharmaceuticals PLC | 598,327 | $113M | 5.7% |
| VERA | Vera Therapeutics Inc | 2,793,987 | $112M | 5.6% |
| UTHR | United Therapeutics Corp | 160,070 | $95M | 4.8% |
| AZN | AstraZeneca PLC | 456,031 | $90M | 4.5% |
| COGT | Cogent Biosciences Inc | 2,113,551 | $81M | 4.1% |
| RARE | Ultragenyx Pharmaceutical Inc | 3,145,888 | $66M | 3.3% |
| RAPP | Rapport Therapeutics Inc | 1,904,408 | $60M | 3.0% |
| INSM | Insmed Inc | 346,075 | $57M | 2.8% |
Track Sofinnova Investments's 13F portfolio: $2.0B in reported holdings, 76 positions. Top holdings and quarterly changes on SentiSense.